Oramed Pharmaceuticals, Inc. (ORMP)

3.39 +0.07 (+2.11%) USD  |  NASDAQ  |  Jan 23, 16:00
3.40 +0.01 (+0.29%) Pre-Market: 20:00
More

Oramed Pharmaceuticals Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for ORMP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Lifeward Ltd. Upgrade
Bristol Myers Squibb Co. Upgrade
Nektar Therapeutics Upgrade
Innoviva, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade